BRPI0815918A2 - Processos de purificação de fviii ou de fvw a partir de uma solução e de obtenção de um fviii purificado e de um fvw purificado. - Google Patents

Processos de purificação de fviii ou de fvw a partir de uma solução e de obtenção de um fviii purificado e de um fvw purificado.

Info

Publication number
BRPI0815918A2
BRPI0815918A2 BRPI0815918-1A2A BRPI0815918A BRPI0815918A2 BR PI0815918 A2 BRPI0815918 A2 BR PI0815918A2 BR PI0815918 A BRPI0815918 A BR PI0815918A BR PI0815918 A2 BRPI0815918 A2 BR PI0815918A2
Authority
BR
Brazil
Prior art keywords
fviii
vwf
purified
obtaining
solution
Prior art date
Application number
BRPI0815918-1A2A
Other languages
English (en)
Inventor
Michel Poulle
Patrick Bonneel
Original Assignee
Lfb Biotechnologies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lfb Biotechnologies filed Critical Lfb Biotechnologies
Publication of BRPI0815918A2 publication Critical patent/BRPI0815918A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0815918-1A2A 2007-08-30 2008-08-28 Processos de purificação de fviii ou de fvw a partir de uma solução e de obtenção de um fviii purificado e de um fvw purificado. BRPI0815918A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0757266A FR2920429B1 (fr) 2007-08-30 2007-08-30 Procede de purification du facteur viii et du facteur von willebrand
PCT/FR2008/051543 WO2009030866A2 (fr) 2007-08-30 2008-08-28 Procede de purification du facteur viii et du facteur von willebrand

Publications (1)

Publication Number Publication Date
BRPI0815918A2 true BRPI0815918A2 (pt) 2015-02-18

Family

ID=39463904

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0815918-1A2A BRPI0815918A2 (pt) 2007-08-30 2008-08-28 Processos de purificação de fviii ou de fvw a partir de uma solução e de obtenção de um fviii purificado e de um fvw purificado.

Country Status (12)

Country Link
US (1) US20100305305A1 (pt)
EP (1) EP2183269A2 (pt)
JP (2) JP5704918B2 (pt)
KR (1) KR20100058520A (pt)
CN (1) CN101796065A (pt)
AR (1) AR068132A1 (pt)
AU (1) AU2008294610A1 (pt)
BR (1) BRPI0815918A2 (pt)
CA (1) CA2697404A1 (pt)
FR (1) FR2920429B1 (pt)
TW (1) TW200918145A (pt)
WO (1) WO2009030866A2 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2920429B1 (fr) * 2007-08-30 2012-10-05 Lfb Biotechnologies Procede de purification du facteur viii et du facteur von willebrand
US11197916B2 (en) 2007-12-28 2021-12-14 Takeda Pharmaceutical Company Limited Lyophilized recombinant VWF formulations
WO2009086400A2 (en) * 2007-12-28 2009-07-09 Baxter International Inc. Recombinant vwf formulations
FR2933496B1 (fr) * 2008-07-02 2012-10-05 Lfb Biotechnologies Procede de mesure du taux de facteur vii active dans un echantillon
DK2349314T3 (da) * 2008-10-21 2013-05-27 Baxter Int Lyofiliserede præparater af rekombinant VWF
NZ602852A (en) * 2010-04-30 2014-03-28 Asahi Kasei Pharma Corp Highly-purified soluble thrombomodulin and method for producing same
AU2011343813B2 (en) * 2010-12-15 2015-05-21 Takeda Pharmaceutical Company Limited Eluate collection using conductivity gradient
WO2013083858A1 (en) * 2012-04-24 2013-06-13 Novo Nordisk A/S Compounds suitable for treatment of haemophilia
US20140154233A1 (en) * 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
US10246485B2 (en) * 2013-11-08 2019-04-02 Csl Limited Method to concentrate von willebrand factor or complexes thereof
AU2015207472B2 (en) * 2014-01-20 2018-11-22 Octapharma Ag A process for manufacturing factor VIII having an improved ratio of FVIII:C/FVIII:Ag
GB201506113D0 (en) * 2015-04-10 2015-05-27 Ge Healthcare Bio Sciences Ab Method for chromatography
GB201506117D0 (en) * 2015-04-10 2015-05-27 Ge Healthcare Bio Sciences Ab Method for chromatography
CA3079956C (en) * 2017-10-27 2023-06-27 Green Cross Holdings Corporation Method for preparing composition containing factor 8 capable of controlling content of von willebrand factor (vwf) and von willebrand factor
US11161065B2 (en) * 2018-04-19 2021-11-02 Waters Technologies Corporation Filtration device for chromatographic instruments
CN109705208B (zh) * 2018-12-29 2022-04-26 山东泰邦生物制品有限公司 一种单步层析制备高纯度血管性血友病因子的工艺

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198349A (en) * 1986-01-03 1993-03-30 Genetics Institute, Inc. Method for producing factor VIII:C and analogs
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
FR2673632A1 (fr) * 1991-03-08 1992-09-11 Lille Transfusion Sanguine Procede de preparation de concentre de facteur von willebrand humain de tres haute purete, approprie a un usage therapeutique.
US5693506A (en) * 1993-11-16 1997-12-02 The Regents Of The University Of California Process for protein production in plants
US5880327A (en) * 1994-09-21 1999-03-09 American National Red Cross Transgenic mammals expressing human coagulation factor VIII
DE4435485C1 (de) * 1994-10-04 1996-03-21 Immuno Ag Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor
AT404358B (de) * 1997-02-04 1998-11-25 Immuno Ag Verfahren zur chromatographischen reinigung bzw. fraktionierung von von willebrand-faktor aus einem vwf-hältigen ausgangsmaterial
AT406867B (de) * 1997-02-27 2000-10-25 Immuno Ag Verfahren zur gewinnung von hochreinem vwf oder faktor viii/vwf-komplex
FR2772381B1 (fr) * 1997-12-15 2001-06-08 Lab Francais Du Fractionnement Procede de preparation par filtration d'une solution de facteur viii securisee viralement
EP1049716A4 (en) * 1998-01-23 2002-07-03 Csl Ltd PURIFICATION OF FIBRINOGEN
US20050060775A1 (en) * 1998-05-14 2005-03-17 Hooker Brian S. Production of human coagulation factor VIII from plant cells and whole plants
US6331416B1 (en) * 1999-06-10 2001-12-18 Cbd Technologies Ltd. Process of expressing and isolating recombinant proteins and recombinant protein products from plants, plant derived tissues or cultured plant cells
EP1148063A1 (de) * 2000-04-18 2001-10-24 Octapharma AG Haemostatisch aktives vWF enthaltendes Präparat und Verfahren zu seiner Herstellung
AUPR110100A0 (en) * 2000-10-30 2000-11-23 Life Therapeutics Limited Improved separation of macromolecules
FR2861395B1 (fr) * 2003-10-23 2006-02-17 Lab Francais Du Fractionnement Facteur viii viralement securise a faible teneur en multimeres superieurs
DE102004009400A1 (de) * 2004-02-24 2005-09-08 Zlb Behring Gmbh Fibrinogen Reinigung
FR2874216B1 (fr) * 2004-08-16 2006-11-03 Lab Francais Du Fractionnement Procede de preparation d'un concentre de facteur von willebrand (fvw) par voie chromatographique et concentre de fvw susceptible d'etre ainsi obtenu
DK1807101T3 (en) * 2004-09-30 2016-05-23 Bayer Healthcare Llc Devices and methods for integrated continuous production of biological molecules
US20070011752A1 (en) * 2005-05-06 2007-01-11 American Integrated Biologics, Inc. Production of human proteins in transgenic animal saliva
US8969532B2 (en) * 2006-10-03 2015-03-03 Novo Nordisk A/S Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
FR2920429B1 (fr) * 2007-08-30 2012-10-05 Lfb Biotechnologies Procede de purification du facteur viii et du facteur von willebrand

Also Published As

Publication number Publication date
AU2008294610A1 (en) 2009-03-12
FR2920429A1 (fr) 2009-03-06
JP2015042687A (ja) 2015-03-05
WO2009030866A2 (fr) 2009-03-12
FR2920429B1 (fr) 2012-10-05
CN101796065A (zh) 2010-08-04
JP2010537960A (ja) 2010-12-09
WO2009030866A3 (fr) 2009-05-07
TW200918145A (en) 2009-05-01
US20100305305A1 (en) 2010-12-02
AR068132A1 (es) 2009-11-04
JP5704918B2 (ja) 2015-04-22
KR20100058520A (ko) 2010-06-03
EP2183269A2 (fr) 2010-05-12
CA2697404A1 (fr) 2009-03-12

Similar Documents

Publication Publication Date Title
FR2921499B1 (fr) Structure orientable de type catheter ou endoscope
EP2411973A4 (en) LIGHTING PANEL
EP2126962A4 (en) SEALED LIGHTING UNITS
EP2195270A4 (en) LIFT SYSTEM
IL209719A0 (en) Fviii muteins for treatment of von willebrand disease
BRPI0811678A2 (pt) "aparelho de iluminação"
BRPI0809866A2 (pt) "conjuntos multicamada"
BRPI1013015A2 (pt) "osteosíntese com nanoprata"
EP2256030A4 (en) AIRCRAFT GROUP
BRPI0813425A2 (pt) Junção de sangria
EP2128071A4 (en) LIFT SYSTEM
FR2915075B1 (fr) Article d'entretien.
PT2441775T (pt) Antigénio linfocitário 75 (ly75)
EP2168898A4 (en) LIFT SYSTEM
EP2123234A4 (en) ORTHODONTIC IMPLANT
EP1891999A4 (en) BLOOD CLEANER
EP2213220A4 (en) ENDOSCOPE SYSTEM
EP2382313A4 (en) NANOSCALE DECONTAMINATION COMPOUNDS ON ENZYME BASIS
EP2141107A4 (en) LIFT SYSTEM
BRPI0810774A2 (pt) composição de cuidado oral ou cuidado corporal.
EP2511217A4 (en) LIFT SYSTEM
EP2246285A4 (en) LIFT SYSTEM
DE602007014191D1 (en) Malatsalze und polymorphe von (3s,5s)-7-ä3-amino-5-methyl-piperidinylü-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure
BRPI0716374A2 (pt) "dispositivos médicos"
EP2216283A4 (en) LIFT SYSTEM

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.